Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02853929 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

551

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Hepatitis B
Acellular Pertussis
Haemophilus Influenzae Type b
Tetanus
Poliomyelitis
Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Interventions

BIOLOGICAL: Infanrix hexa

Sponsor

GlaxoSmithKline